Results 111 to 120 of about 47,270 (166)

[Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhan S, Chen P, Lv T, Song Y.
europepmc   +1 more source

[Ethanol promotes oxaliplatin resistance in colorectal cancer by activating the TGF‑β/Smad/P21 signaling axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Tan B, Weng N, Zeng W, Gu J, Weng L, Wen H, Xiao H, Zheng K.   +7 more
europepmc   +1 more source

[<i>MUTYH-APEX1</i> Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhou Y, Zhang H, Zhu Y, Jiang P, Feng T, Wu Z, Chen J.   +6 more
europepmc   +1 more source

Transtext(e)s Transcultures è,è - Journal of Global Cultural Studies

Cléo Radar, 2009
openaire   +1 more source

[Research progress on poor response, resistance mechanisms, and influencing factors of immunotherapy for hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang M, Zhang FN, Gong H, Liu CC, Zhao TT, He N.   +5 more
europepmc   +1 more source

[Tumor-secreted dentin sialophosphoprotein induces oxaliplatin resistance in colorectal cancer through an integrin αvβ3-dependent pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu C, Ning Z, Wu J, Liu W, Lin C, Xu J, Zhou R, Zhao L.   +7 more
europepmc   +1 more source

[Molecular Epidemiology and Fluconazole Resistance Mechanisms in <i>Candida tropicalis</i> Isolates From Bloodstream Infections in Sichuan, China]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen W, Hou J, Peng L, Kang M, Ma Y.
europepmc   +1 more source

[Mechanisms and clinical research progress of mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang N, Xu ZL, Liu DH.
europepmc   +1 more source

顺铂耐药卵巢癌细胞化疗敏感性实验

, 2009
【目的】 研究顺铂(DDP)。洛铂(LBP)。紫杉醇(PTX)。吉西他滨(GEM)对卵巢癌SKOV3细胞及顺铂耐药SKOV3 /DDP细胞增殖的影响。【方法】 培养基中不含药物的处理组为对照组,加入不同浓度化疗药物的处理组为实验组。在相差显微镜下观察细胞形态变化;用MTT法测定单药应用。双药联合使用对两种细胞生长的影响;流式细胞仪分析细胞周期和凋亡率的变化。【结果】 SKOV3∕DDP细胞耐药指数为7.10 ± 2.19。紫杉醇。洛铂。吉西他滨对两种细胞的抑制率无明显差别。洛铂。紫杉醇 ...

core  

[<i>Shengmai San</i> improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liang Z, Pan F, Deng L, Mai Z, Ma Y, Shi C, Fu W.   +6 more
europepmc   +1 more source